This #IndependenceDay, we celebrate the spirit of independence and honor the service members who have fought to protect it. Wishing everyone a safe and happy holiday as we appreciate the day, the traditions, and those who have made it possible. #4thofJuly

Our team was honored to join the @NPF’s Commit to Cure Gala in NYC last week. We're inspired by the dedication to #Psoriasis & psoriatic arthritis research. Here’s to making strides toward a cure. #CommitToCure #NPFGala

#NEWS: Today we announced that our topical cream has received a strong recommendation in the American Academy of Dermatology’s updated guidelines for adults with mild to moderate #AtopicDermatitis. Learn more: #ClinicalDermatology

We’re excited to share #ArcutisCorner, a bi-monthly guide for NPs, PAs, and residents—peer-review tips and methodology deep dives. Check out the latest issue that covers building consensus when data is scarce. Learn more:

Thanks, @Nasdaq for the shoutout! We’re thrilled about the #FDA approval of our topical treatment for plaque psoriasis. This is another example of how we champion #MeaningfulInnovation for serious #SkinDiseases. $ARQT #ThisIsArcutUS

#NEWS: Today we announced the enrollment of the first child in a Phase 2 study evaluating our investigational non-steroid topical treatment in infants as young as three months up to 24 months with #AtopicDermatitis. Learn more: #ClinicalDermatology

We’re excited to be in sunny Miami this week for the Goldman Sachs 46th Annual Global Healthcare Conference, where Arcutis President and CEO, Frank Watanabe, will be hosting a fireside chat. Full details below. #ClinicalDermatology $ARQT

Happy #PrideMonth! 🌈 We honor the love, resilience & diversity of LGBTQIA+ communities that inspire our #CompanyCulture. At Arcutis, we stand with our LGBTQIA+ colleagues, partners & those living with inflammatory skin disease—today & always. #ThisIsArcutUS

#NEWS: This week, our team is at the 2025 Revolutionizing Atopic Dermatitis (RAD) Conference in Nashville where we’ll be presenting data from our recent studies in #AtopicDermatitis. Learn more: #RAD2025 #AtopicDermatitis

We’re excited to come together as a team to celebrate the launch of our topical foam for scalp and body #psoriasis. #ThisisArcutUS #MeaningfulInnovation

#NEWS: We’re honored that our targeted topical treatment for #psoriasis is the first FDA-approved treatment to receive the @NPF Seal of Recognition. Thank you to our entire Arcutis team for your contributions to #MeaningfulInnovation in #dermatology!

Celebrating 9 years of Arcutis Biotherapeutics! Thanks to our longest-tenured team members for laying the foundation for people-first breakthroughs—and to everyone driving #MeaningfulInnovation in #ClinicalDermatology. #ThisIsArcutUS

#ICYMI last week we shared our latest #CompanyMilestone with the @US_FDA approval of our advanced targeted topical foam treatment for scalp and body #psoriasis. Read the release: #ClinicalDermatology #FDAapproval #MeaningfulInnovation

#ICYMI The Genital Psoriasis Wellness Consortium, a multidisciplinary group of clinician experts in the management of genital psoriasis, recently published 14 consensus statements aimed at improving diagnosis and quality of life. Read more:

On Memorial Day, we honor the brave individuals who gave their lives in service to our country. Their sacrifice reminds us of the profound strength, courage, and dedication it takes to protect what matters most. 🇺🇸. #RememberandHonor #NeverForgotten

#NEWS: We're excited to share that the U.S. FDA has approved our topical, steroid-free foam for treating #psoriasis of the scalp and body. Learn more about this breakthrough: #CompanyMilestone #FDAapproval #SkinHealth #Innovation

In honor of Mental Health Awareness Month, we asked Diane Hanna, VP Medical Affairs, to describe three ways people with chronic inflammatory skin diseases experience the mental and emotional burden of living with it. #MentalHealthAwarenessMonth #MentalHealthMatters

#NEWS Today, we announced the publication of 14 consensus statements from the Genital Psoriasis Wellness Consortium on the impact of genital psoriasis on patients in @TheJEADV. Read more:

Happy #InternationalNursesDay! We’re incredibly proud to have eight outstanding nurses and nurse practitioners on our team. Join us in celebrating their knowledge, empathy and unwavering commitment to patient care. #NationalNursesWeek #ThisIsArcutUS #DermatologyNursing

We're thrilled to officially welcome Latha Vairavan into her new role as Chief Financial Officer! Her strategic insight and financial acumen have been instrumental to our growth. We're excited to see her lead in this next chapter. Congrats Latha, on a well-deserved promotion!